Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

1437P Tislelizumab (TIS) + Chemotherapy (CT) Vs Placebo (PBO) + CT in HER2-negative Advanced or Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma (GC/GEJC): RATIONALE-305 Study Minimum 3-Year Survival Follow-Up

M. Cruz-Correa, D-Y. Oh, K. Kato,J. Tabernero,Y. Bai,J. Shi,K-W. Lee, H. Hirano,D.R. Spigel,L.S. Wyrwicz,R.A. Pazo Cid,A. Cubillo Gracian, L. Li, Y. Xu,T. Sheng, S. Yang,R-H. Xu,M. Moehler

Annals of Oncology（2024）

Cited 0|Views5
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined